These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2439806)

  • 1. Noninvasive assessment of left ventricular performance after administration of bisoprolol.
    Esper RJ; Esper RC; Burrieza OH; Menna J
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S87-91. PubMed ID: 2439806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of bisoprolol on cardiac performance in coronary heart disease.
    Maisch B; Borst U; Gerhards W; Wagner G
    Eur J Clin Pharmacol; 1989; 36(3):217-22. PubMed ID: 2568261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive effects of bisoprolol during once daily administration in patients with essential hypertension. A dose-ranging study with parallel groups.
    Weiner L; Frithz G
    Eur J Clin Pharmacol; 1986; 29(5):517-21. PubMed ID: 2869951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of bisoprolol fumarate on left ventricular size, function, and exercise capacity in patients with heart failure: analysis with magnetic resonance myocardial tagging.
    Dubach P; Myers J; Bonetti P; Schertler T; Froelicher V; Wagner D; Scheidegger M; Stuber M; Luchinger R; Schwitter J; Hess O
    Am Heart J; 2002 Apr; 143(4):676-83. PubMed ID: 11923805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of different bisoprolol doses on hemodynamics, plasma catecholamines, platelet aggregation, and alpha 2- and beta-receptors in hypertensive patients.
    Kirsten R; Neff J; Heintz B; Nemeth N; Rahlfs VW; Nelson K
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S113-21. PubMed ID: 2439781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systolic time intervals as possible predictors of pressure response to sustained beta-adrenergic blockade in arterial hypertension. A within-patient, placebo-controlled study.
    Verdecchia P; Brignole M; Delfino G; Queirolo C; De Marchi G; Bertulla A
    Hypertension; 1983; 5(1):140-6. PubMed ID: 6336719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of the effect of bisoprolol in dilated cardiomyopathy.
    Nyolczas N; Dekány M; Fiók J; Prëda I
    Cardiovasc Drugs Ther; 2000 Oct; 14(5):543-50. PubMed ID: 11101203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-effect relationship and long-term effects of bisoprolol in mild to moderate hypertension.
    Weiner L; Frithz G
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S106-12. PubMed ID: 2439780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative dose titration responses to the introduction of bisoprolol or carvedilol in stable chronic systolic heart failure.
    Hamaad A; Lip GY; Nicholls D; MacFadyen RJ
    Cardiovasc Drugs Ther; 2007 Dec; 21(6):437-44. PubMed ID: 17896170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta blockers therapy is associated with improved left ventricular systolic function and sustained exercise capacity in elderly patients with heart failure. CIBIS-ELD sub-study.
    Dekleva M; Düngen HD; Gelbrich G; Incrot S; Suzic Lazic J; Pavlovic Kleut M; Tahirovic E; Waagstein F
    Aging Clin Exp Res; 2012 Dec; 24(6):675-81. PubMed ID: 23147689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evaluation of bisoprolol in patients with hypertension: interim report.
    Ikeda M; Inagaki Y; Iimura O; Kuramoto K; Takeda T
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S139-42. PubMed ID: 2439785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter evaluation of the hemodynamic effects of bisoprolol in patients with mild to moderate hypertension.
    Prisant LM; Carr AA; Desnoyers M; Westcott RJ; Zinny MA; O'Donnell DM; Bryzinski B; McKee B; Nelson BR
    J Clin Pharmacol; 1990 Dec; 30(12):1096-101. PubMed ID: 1980278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative cardiac haemodynamics of bisoprolol, celiprolol, carvedilol and nebivolol in normal volunteers.
    De Cree J; Van Nueten L; Geukens H; Verhaegen H
    Int J Clin Pharmacol Res; 1992; 12(4):159-63. PubMed ID: 1363660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial Effect on Surrogate Markers of Heart Failure with Bisoprolol Up-Titration to Recommended Targets in Korean Patients with Heart Failure and Left Ventricular Systolic Dysfunction.
    Han SW; Choi SW; Ryu KH; Kim HJ; Kim SH; Shim WJ; Cha TJ; Choi DJ; Kim YJ; Yoo BS; Kim JH; Hwang KK; Jeon H; Shin MS
    Cardiovasc Ther; 2016 Jun; 34(3):172-9. PubMed ID: 27003232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of bisoprolol in relation to metoprolol and bufuralol on left ventricular hemodynamics at rest and during exercise in chronic ischemic heart disease.
    Burkart F; Pfisterer M; Steinmann E
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S78-82. PubMed ID: 2439804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of beta-blockers on ventilation efficiency in heart failure.
    Agostoni P; Apostolo A; Cattadori G; Salvioni E; Berna G; Antonioli L; Vignati C; Schina M; Sciomer S; Bussotti M; Palermo P; Fiorentini C; Contini M
    Am Heart J; 2010 Jun; 159(6):1067-73. PubMed ID: 20569721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [BNP and echocardiography can predict the occurrence of acute cardiac decompensation during titration of bisoprolol in chronic systolic heart failure].
    Ben Driss A; Tabet JY; Meurin P; Weber H; Renaud N; Grosdemouge A; Bourmayan C
    Arch Mal Coeur Vaiss; 2007 Nov; 100(11):934-40. PubMed ID: 18209694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical, hemodynamic and neurohumoral effects of long-term therapy of patients with severe chronic heart failure with beta-adrenoblocker bisoprolol].
    Belenkov IuN; Skvortsov AA; Mareev VIu; Nasonova SN; Sychev AV; Narusov OIu; Baklanova NA; Masenko VP
    Kardiologiia; 2003; 43(10):10-21. PubMed ID: 14593351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
    J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Summary of short- and long-term studies with bisoprolol in coronary heart disease (CHD).
    Wagner G
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S160-6. PubMed ID: 2439790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.